The original trial registration for this Research paper (*BMJ* 2015;351:h5627, doi:10.1136/bmj.h5627), the REEACT trial (<http://www.controlled-trials.com/ISRCTN91947481>), included depression as a primary outcome, measured in two ways: "Depression severity and symptomatology as measured by a validated self-report measure (the Patient Health Questionnaire \[PHQ-9\]) and the International Classification of Diseases (ICD-10) depression score at four months." The original protocol defined the primary outcome measure as "depression severity and symptomatology as measured by the PHQ-9 and a self-report computer-administered diagnostic interview (CIS-R) at four months." Before the start of the trial, the primary outcome measure was modified to consist of only the PHQ-9 at four months. We did not collect ICD diagnosed depression using a standardised interview schedule. The public document detailing all revisions can be accessed in the full report at [http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-101\#chapters/2](http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-101#chapters%2F2). One of our outcomes was a measure of quality adjusted life years, which is published in the full economic evaluation at [http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-101\#chapters/4](http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-101#chapters%2F4).
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